Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 24834 | 250 | 29.6 | 36% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 3851 | 582 | CU GNRH//GRP MED PHARMACOL TOXICOL//GRP GYNAECOL ONCOL |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | CU GNRH | Author keyword | 3 | 100% | 1% | 3 |
| 2 | GRP MED PHARMACOL TOXICOL | Address | 2 | 67% | 1% | 2 |
| 3 | GRP GYNAECOL ONCOL | Address | 1 | 100% | 1% | 2 |
| 4 | C4 I CELLS | Author keyword | 1 | 50% | 0% | 1 |
| 5 | CYCLIC GUANOSINE MONOPHOSPHATE C GMP | Author keyword | 1 | 50% | 0% | 1 |
| 6 | EXTRACELLULAR CGMP | Author keyword | 1 | 50% | 0% | 1 |
| 7 | HYPOTHALAMIC TISSUE | Author keyword | 1 | 50% | 0% | 1 |
| 8 | PHYSIOLOGICAL IMPLICATIONS | Author keyword | 1 | 50% | 0% | 1 |
| 9 | REAL TIME PCR NORMALIZATION | Author keyword | 1 | 50% | 0% | 1 |
| 10 | STERLINGS HOSP | Address | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | CU GNRH | 3 | 100% | 1% | 3 | Search CU+GNRH | Search CU+GNRH |
| 2 | C4 I CELLS | 1 | 50% | 0% | 1 | Search C4+I+CELLS | Search C4+I+CELLS |
| 3 | CYCLIC GUANOSINE MONOPHOSPHATE C GMP | 1 | 50% | 0% | 1 | Search CYCLIC+GUANOSINE+MONOPHOSPHATE+C+GMP | Search CYCLIC+GUANOSINE+MONOPHOSPHATE+C+GMP |
| 4 | EXTRACELLULAR CGMP | 1 | 50% | 0% | 1 | Search EXTRACELLULAR+CGMP | Search EXTRACELLULAR+CGMP |
| 5 | HYPOTHALAMIC TISSUE | 1 | 50% | 0% | 1 | Search HYPOTHALAMIC+TISSUE | Search HYPOTHALAMIC+TISSUE |
| 6 | PHYSIOLOGICAL IMPLICATIONS | 1 | 50% | 0% | 1 | Search PHYSIOLOGICAL+IMPLICATIONS | Search PHYSIOLOGICAL+IMPLICATIONS |
| 7 | REAL TIME PCR NORMALIZATION | 1 | 50% | 0% | 1 | Search REAL+TIME+PCR+NORMALIZATION | Search REAL+TIME+PCR+NORMALIZATION |
| 8 | LUTEINIZING HORMONE RELEASING HORMONE RELEASE | 0 | 33% | 0% | 1 | Search LUTEINIZING+HORMONE+RELEASING+HORMONE+RELEASE | Search LUTEINIZING+HORMONE+RELEASING+HORMONE+RELEASE |
| 9 | ME 180 | 0 | 20% | 0% | 1 | Search ME+180 | Search ME+180 |
| 10 | C 33A | 0 | 14% | 0% | 1 | Search C+33A | Search C+33A |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ISOLATED HYPOTHALAMIC GRANULES | 6 | 80% | 2% | 4 |
| 2 | MEDIAN EMINENCE EXPLANTS | 5 | 55% | 2% | 6 |
| 3 | CHELATED COPPER | 4 | 75% | 1% | 3 |
| 4 | PROSTAGLANDIN E2 STIMULATION | 3 | 100% | 1% | 3 |
| 5 | C4 I CELLS | 1 | 100% | 1% | 2 |
| 6 | COPPER STIMULATION | 1 | 100% | 1% | 2 |
| 7 | PIGEON ERYTHROCYTES | 1 | 30% | 1% | 3 |
| 8 | CYCLIC NUCLEOTIDE LEVELS | 1 | 17% | 2% | 5 |
| 9 | 3 5 CYCLIC MONOPHOSPHATE CGMP | 1 | 50% | 0% | 1 |
| 10 | MOSAIC MUTATION | 1 | 50% | 0% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| CAMP EXPORT AND ITS REGULATION BY PROSTAGLANDIN-A1 | 1988 | 29 | 9 | 56% |
| Involvement of copper in female reproduction | 2007 | 5 | 41 | 32% |
| THE EGRESS OF CYCLIC-AMP FROM METAZOAN CELLS | 1983 | 110 | 6 | 67% |
| Cu-GnRH - new gonadoliberin (GnRH) analog | 2013 | 0 | 33 | 48% |
| LEVAMISOL AND ITS ANALOGS .1. METHODS OF SYNTHESIS - REVIEW | 1989 | 2 | 10 | 50% |
| A RADIOIMMUNOASSAY FOR CYCLIC-GMP WITH FEMTOMOLE SENSITIVITY USING TRITIATED LABEL AND ACETYLATED LIGANDS | 1985 | 3 | 1 | 100% |
| USE OF METAL-COMPLEXES IN NEURO-ENDOCRINE STUDIES | 1989 | 1 | 19 | 47% |
| Efflux of cyclic adenosine monophosphate from cells: Mechanisms and physiological implications | 1999 | 11 | 46 | 15% |
| CYCLIC-NUCLEOTIDES IN CLINICAL ONCOLOGY | 1982 | 3 | 14 | 43% |
| Can melatonin regulate the expression of prohormone convertase 1 and 2 genes via monomeric and dimeric forms of RZR/ROR nuclear receptor, and can melatonin influence the processes of embryogenesis or carcinogenesis by disturbing the proportion of cAMP and cGMP concentrations? Theoretic model of controlled apoptosis | 2001 | 5 | 124 | 2% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | GRP MED PHARMACOL TOXICOL | 2 | 67% | 0.8% | 2 |
| 2 | GRP GYNAECOL ONCOL | 1 | 100% | 0.8% | 2 |
| 3 | STERLINGS HOSP | 1 | 50% | 0.4% | 1 |
| 4 | UMR 7079 PHYSIOL PHYSIOPATHOL | 0 | 33% | 0.4% | 1 |
| 5 | PHYS CHEM BIOMEMBRANES | 0 | 14% | 0.4% | 1 |
| 6 | FIZJOLOGII ZYWIENIA ZWIERZAT | 0 | 100% | 0.4% | 1 |
| 7 | PHYSIOL CLIN HOSP 3ENDOCRINOL UNIT | 0 | 100% | 0.4% | 1 |
| 8 | REGULAT GENES PHYSIOL AXE GONADOTROPE | 0 | 100% | 0.4% | 1 |
| 9 | ZAKLAD NEUROENDOKRYNOLOGII | 0 | 100% | 0.4% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000087563 | RURAL CRYOGEN TECHNOL//ECTOPROTEIN KINASE//EXTRACELLULAR PHOSPHORYLATION |
| 2 | 0.0000064248 | MRP1//MULTIDRUG RESISTANCE ASSOCIATED PROTEIN//DUBIN JOHNSON SYNDROME |
| 3 | 0.0000061290 | POST P MED//USTAV ORGAN CHEM BIOCHEM//ADPFE NADPH INDUCED LIPID PEROXIDATION |
| 4 | 0.0000056071 | EXPT INVEST//PLASMA CAMP//SARATOV SCI VET |
| 5 | 0.0000054483 | VIBRISSAL MOVEMENTS//HYPOTHALAMO//ADRENOBLOCKERS |
| 6 | 0.0000053394 | CARDIAC HORMONE//VESSEL DILATOR//KALIURETIC PEPTIDE |
| 7 | 0.0000050388 | CELLULAR BIOCHEM SECT//8 CL CAMP//8 CHLORO ADENOSINE |
| 8 | 0.0000047353 | CNGC//CYCLIC CMP//CYCLIC NUCLEOTIDE GATED ION CHANNEL |
| 9 | 0.0000045506 | SPECTRUM STRUCTURE CORRELATION//GHK//EVANS CHEM |
| 10 | 0.0000045070 | COLEUS FORSKOHLII//NKH477//COLFORSIN DAROPATE |